MD, FRCPC, FCCP
Professor, Department of Medicine, Laval University
Lung Specialist, l’Institut universitaire de cardiologie et de pneumologie de Québec (iuCPQ)
Chairholder, Knowledge Transfer, Training and Prevention Chair on Respiratory and Cardiovascular Health
Dr. Boulet is a respirologist at the Institut de cardiologie et de pneumologie de Québec (Quebec Heart and Lung Institute), a professor of medicine at the Department of Medicine of Laval University, and holds a chair in Knowledge Translation, Education and Prevention in Respiratory and Cardiorespiratory Health at Laval University. He is also Chair of the Board of Directors of the Global Initiative for Asthma (GINA); first vice-president of InterAsma, the Global Asthma Association; and a member of many Canadian and International medical societies and guidelines committees. He is past chair of the Canadian Thoracic Society (CTS) and of the CTS Respiratory Guidelines Committee, and was a founding member of the Quebec Respiratory Health Education Network.
In addition to his clinical practice and teaching, Dr. Boulet runs a research program focused mainly on the themes of asthma phenotypes; airway responses, inflammation and remodelling; respiratory allergy; respiratory health of athletes; and knowledge translation and health education. His research seeks to establish links between basic and clinical science in the field of asthma and respiratory allergy. He has undertaken collaborative studies on the mechanisms of asthma development, with a particular focus on: airway function; inflammation and structure changes in high-risk groups; and the influence of obesity, high-level exercise training (athletes), exposure to substances such as allergens and occupational agents, and various therapeutic and educational interventions.
Dr. Boulet is frequently invited as a speaker at national and international meetings. He has written more than 650 medical publications, in addition to 633 abstracts and 43 book chapters, and he has edited/authored 17 books.
All CIC publications featuring Dr. Boulet as a co-author are listed below.
Author(s) | Year | Title | Journal |
---|---|---|---|
Gauvreau GM, FitzGerald JM, Boulet L-P, Watson R, Hui L, Villeneuve H, Scime T, Schlatman A, Obminski C, Kum J, Boehme S, Ly TW, Bacon K, O'Byrne PM | 2018 | The Effects of a CCR3 Inhibitor, AXP1275, on Allergen-Induced Airway Responses in Adults with Mild-to Moderate Atopic Asthma | Clinical & Experimental Allergy |
Singh A, Shannon CP, Kim YW, Yang CX, Balshaw R, Cohen Freue GV, Gauvreau GM, FitzGerald JM, Boulet L-P, O'Byrne PM, Tebbutt SJ | 2018 | Novel blood-based transcriptional biomarker panels predict the late phase asthmatic response | American Journal of Respiratory and Critical Care Medicine |
Revez JA, Killian KJ, O'Byrne PM, Boulet LP, Upham JW, Gauvreau GM, Ferreira MAR | 2018 | Sputum cytology during late-phase responses to inhalation challenge with different allergens | Allergy |
Nair P, Martin JG, Cockcroft DC, Dolovich M, Lemiere C, Boulet LP, O'Byrne PM | 2017 | Airway Hyperresponsiveness in Asthma: Measurement and Clinical Relevance | Journal of Allergy and Clinical Immunology: In Practice |
Blais C, Cockcroft DW, Veilleux J, Boulay ME, Boulet L-P, Gauvreau GM, Scime TX, Watson RM, O’Byrne PM, Davis BE | 2017 | Methacholine challenge: comparison of airway responsiveness produced by a vibrating mesh nebulizer versus a jet nebulizer | Journal of Aerosol Medicine and Pulmonary Drug Delivery |
Gauvreau GM, Boulet LP, Leigh R, Cockcroft DW, Davis BE, Mayers I et al. | 2016 |
Journal of Allergy and Clinical Immunology |
|
Todd CM, Salter BM, Murphy DM, Watson RM, Howie KJ, Milot J, Sadeh J, Boulet LP, O'Byrne PM, Gauvreau GM | 2016 |
The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects |
Pulmonary Pharmacology and Therapeutics |
Gauvreau GM, Boulet LP, FitzGerald JM, Cockcroft DW, Davis BE, Leigh R, Tanaka M, Fourre JA, Tanaka M, Nabata T, O'Byrne PM | 2016 |
Allergy |
|
Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria JP, O'Byrne P, Gauvreau G, Boulet L-P, Lemiere C, Martin JG, Nair P, Sehmi R. | 2015 |
Journal of Allergy & Clinical Immunology |
|
Ellis A, Soliman M, Steacy L, Boulay M, Boulet L, Keith P, Vliagoftis H, Waserman S, Neighbour H | 2015 |
Allergy, Asthma & Clinical Immunology |
|
Boulet LP, Gauvreau GM, Cockcroft DW, Davis B, Vachon L, Cormier Y, O'Byrne PM | 2015 |
Canadian Respiratory Journal |
|
Boulet LP, Gauvreau G, Boulay ME, O'Byrne P, Cockcroft DW | 2015 |
Allergen-induced early and late asthmatic responses to inhaled seasonal and perennial allergens |
Clinical & Experimental Allergy |
Gauvreau GM, Boulet LP, Leigh R, Cockcroft DW, Killian KJ, Davis BE, Deschesnes F, Watson RM, Swystun V, Mårdh CK, Wessman P, Jorup C, Aurivillius M, O'Byrne PM | 2015 |
A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses |
American Journal of Respiratory and Critical Care Medicine |
Gauvreau GM, Harris JM, Boulet LP, Sheerens H, FitzGerald JM, Putnam WS, Cockcroft DW, Davis BE, Leigh R, Zheng Y, Dahlén B, Wang Y, Maciuca R, Mayers I, Liao XC, Wu LC, Matthews JG, O'Byrne PM. | 2014 |
Science Translational Medicine |
|
Gauvreau GM, O'Byrne PM, Boulet L-P, Wang Y, Cockcroft DW, Bigler J, FitzGerald JM, Boedigheimer M, Davis BE, Dias C, Gorski KS, Smith L, Bautista E, Comeau MR, Leigh R, Parnes JR. | 2014 |
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses |
The New England Journal of Medicine |
Gauvreau GM, Boulet L-P, Cockcroft DW, FitzGerald JM, Mayers I, Carlsten C, Laviolette M, Killian KJ, Davis BE, Larché M , Kipling C , Dua B , Mosesova S , Putnam W , Zheng Y, Scheerens H, McClintock D , Matthews J, O'Byrne PM | 2014 |
OX40L blockade on allergen-induced airway responses in subjects with mild asthma |
Clinical Experimental Allergy |
Singh A, Yamamoto M, Kam SHY, Ruan J, Gauvreau GM, O'Byrne PM, FitzGerald JM, Schellenberg R, Boulet L-P, Wojewodka G, Kanagaratham C, De Sanctis J, Radzioch D, Tebbutt SJ. | 2013 |
PLOS ONE |
|
Singh A, Cohen Freue GV, Oosthuizen JL, Kam SHY, Ruan J, Takhar M, Gauvreau GM, O'Byrne PM, FitzGerald JM, Boulet L-P, Borchers CH, Tebbutt SJ. | 2012 | Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge |
Proteomics ? Clinical Applications |
Yamamoto M, Singh A, Ruan J, Gauvreau GM, O'Byrne PM, Carlsten C, FitzGerald JM, Boulet L-P, Tebbutt SJ. | 2012 |
BMC Genomics |
|
Lougheed MD, Lemière C, Ducharme FM, Lickai C, Dell SD, Rowe BH, Fitzgerald M, Leigh R, Watson W, Boulet L-P. | 2012 | Canadian Thoracic Society 2012 Guideline Update: Diagnosis and Management of Asthma in Preschoolers, Children and Adults: Executive Summary |
Canadian Respiratory Journal |
Gauvreau GM, Boulet LP, Cockcroft DW, Fitzgerald JM, Carlsten C, Davis BE, Deschesnes F, Duong M, Durn BL, Howie KJ, Hui L, Kasaian MT, Killian KJ, Strinich TX, Watson RM, Y N, Zhou S, Raible D, O'Byrne PM. | 2011 |
The effects of IL-13 blockade on allergen-induced airway responses in mild atopic asthma |
American Journal of Respiratory and Critical Care Medicine |
Rousseau M-C, Boulay M-E, Goronfolah L, Denburg J, Keith P, Boulet L-P. | 2011 |
Allergy, Asthma & Clinical Immunology |
|
Gaurvreau GM, Boulet LP, Cockcroft DW, FitzGerald JM, Carlsten C, Davis BE, Deschesnes F, Duong M, Durn BL, Howie KJ, Hui L, Kasaian MT, Killian KJ, Strinich TX, Watson RM, Zhou S, Raible D, O'Byrne PM. | 2010 |
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma |
American Journal of Respiratory and Critical Care Medicine |
Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F, Boulet LP, Cockcroft DW. | 2009 |
Single dose desloratadine and montelukast and allergen-induced late airway responses |
European Respiratory Journal |
Boulet L-P, Lemière C, Gauvreau GM, Olivenstein R, Lougheed D, Paradis B, O’Byrne P, Pageau R, Renzi PM. | 2009 |
Safety, pharmacodynamics and pharmacokinetics of TPI 1020 in smokers with asthma |
Respiratory Medicine |
Gauvreau GM, Boulet L-P, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K, Duong M, Watson RM, Renzi PM, O'Byrne, PM. | 2008 | Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses |
American Journal of Respiratory and Critical Care Medicine |
Duong M, Cockcroft D, Boulet L-P, Ahmed T, Iverson H, Atkinson D, Stahl E, Watson R, Davis B, Milo J, Gauvreau G, O'Byrne P. | 2008 |
Allergy |
|
Boulet LP , Prince P , Turcotte H , Lemière C, Olivenstein R, Laprise C, Larivee P , Bégin P, Laviolette M. | 2006 |
Respiratory Medicine |